Keyphrases
Human Epidermal Growth Factor Receptor 2 (HER2)
100%
Gynecologic Malignancies
100%
Anti-human Epidermal Growth Factor Receptor 2
80%
Trastuzumab
60%
Uterine Serous Carcinoma
60%
Targeted Therapy
40%
Therapeutic Target
20%
Overexpressing
20%
Randomized Controlled Trial
20%
Treatment Options
20%
Overexpression
20%
Endometrial Cancer
20%
Tumoral
20%
Cancer Subtypes
20%
Gastric Cancer
20%
Uterine Carcinosarcoma
20%
Human Epidermal Growth Factor Receptor 2-positive Breast Cancer
20%
Medicine and Dentistry
Cancer
100%
Gamma Urogastrone
100%
Epidermal Growth Factor Receptor 2
100%
Uterine Serous Carcinoma
33%
Trastuzumab
33%
Targeted Therapy
22%
Malignant Neoplasm
11%
Disease
11%
Biological Marker
11%
Endometrial Cancer
11%
Randomized Controlled Trial
11%
Carcinosarcoma
11%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
11%
Stomach Cancer
11%
Pharmacology, Toxicology and Pharmaceutical Science
Gamma Urogastrone
100%
Epidermal Growth Factor Receptor 2
100%
Carcinoma
33%
Trastuzumab
33%
Randomized Controlled Trial
11%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
11%
Malignant Neoplasm
11%
Biological Marker
11%
Endometrium Cancer
11%
Stomach Cancer
11%
Carcinosarcoma
11%
Disease
11%